Commentary
Video
Author(s):
Heather A. Parsons, MD, MPH, discusses the correlation between liquid biopsy and HER2 status in breast cancer, according to data from a novel epigenomic platform.
Heather A. Parsons, MD, MPH, medical oncologist, Dana-Farber Cancer Institute, assistant professor, medicine, Harvard Medical School, discusses the correlation between liquid biopsy and HER2 status in breast cancer, according to data from a novel epigenomic platform.